The new pathogenic PTH effects on adipose tissue, previously described, led us to carefully re-evaluate the pathophysiological alterations in HPT, which is typically defined by hypercalcemia and its associated gastrointestinal, renal, and skeletal symptoms [55]. The gene discussed is PTH; the disease is Hypercalcemia.